Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1236 of 5804
-
Can steroids rescue livers damaged by medications?
Disease control Recruiting nowDrug-induced liver injury (DILI) can lead to potentially fatal complications, such as acute liver failure and even death. In clinical practice, glucocorticoids have been considered in some cases of DILI, especially patients with hyperbilirubinemia. However, the available evidence…
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
AI vs. radiologists: can computers spot lung nodules better?
Diagnosis Ongoingchest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI tool, the AI software will generate a report on if it detects a lung nodule or …
Sponsor: University Hospitals Cleveland Medical Center • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Stomach pacemaker could quiet chronic nausea
Symptom relief Recruiting nowThe purpose of this research study is to determine if the Enterra® Therapy System can decrease nausea and vomiting symptoms and improve the quality of life for patients with chronic nausea, with or without vomiting, that have normal gastric emptying.
Phase: NA • Sponsor: Enterra Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New drug aims to stop muscle loss while shedding pounds
Disease control Recruiting nowSemaglutide is approved for weight management (weight loss and weight maintenance) in adult obese patients. Drug treatments like semaglutide that result in weight-loss can also decrease muscle mass. The purpose of this study is to investigate the effect of ACM-001.1 (the study dr…
Phase: PHASE2 • Sponsor: Actimed Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug aims to ease painful mouth sores for head and neck cancer patients
Symptom relief Recruiting nowThis phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis in patients who are receiving chemoradiation for head and neck cancer. Oral mucositis (inflammation and mouth sores) is a…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New scan spots hidden cancer spread before surgery
Diagnosis Recruiting nowThe trial focuses on assessing the role of \[68Ga\]Ga-FAPI-46 in head and neck squamous cell carcinomas (HNSCC) staging before surgery. In the context of metastasis, cancer-associated fibroblasts (CAFs) emerge as pivotal contributors to the creation of a microenvironment conduciv…
Phase: PHASE2 • Sponsor: John O. Prior • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Virus and drug combo takes on tough cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and primary efficacy of the combination therapy of recombinant human IL-21-expressing oncolytic vaccinia virus (hV01) and the PD-1 Inhibitor Tislelizumab in patients with advanced solid tumors.
Phase: NA • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Smart patch could spot silent killer in kidney patients without needles
Diagnosis CompletedThis study aims to evaluate whether hyperkalemia, a potentially life-threatening condition in dialysis patients, can be detected early using a wearable single-lead ECG device. Patients with chronic kidney disease undergoing hemodialysis will wear a chest-attached ECG sensor (HiCa…
Sponsor: Kyungho Park • Aim: Diagnosis
Last updated Jun 27, 2026 11:04 UTC
-
New shot could cool menopause hot flashes
Symptom relief OngoingThe purpose of this study is to evaluate the effects of single and multiple doses of ABCL635 administered by subcutaneous (SC) injection to healthy men and to postmenopausal women with or without any vasomotor symptoms (VMS) or hot flashes, and to postmenopausal women with modera…
Phase: PHASE1, PHASE2 • Sponsor: AbCellera Biologics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a lower drug dose improve life after stem cell transplant for older adults?
Disease control Recruiting nowThis study will compare post-transplant health-related quality of life following the use of standard versus attenuated dose of post-transplant cyclophosphamide in addition to two-drug graft-versus-host disease (GVHD) prophylaxis among recipients of allogeneic hematopoietic stem c…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Scientists redesign trauma therapy to fit school life
Symptom relief Recruiting nowTrauma-focused cognitive behavior therapy (TF-CBT) has the strongest evidence of any clinical intervention for youth trauma but is rarely adopted in the education sector - the most common setting for youth mental healthcare. Use of TF-CBT in schools is limited by (1) problems wit…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New drug safety check for advanced bladder cancer in india
Disease control Recruiting nowThis study is for Indian adults in India who have cancer in the bladder lining (urothelial cancer). Their cancer is advanced or has spread to other parts of the body. Enfortumab vedotin is a treatment for this type of cancer. The main aim of the study is to confirm the safety of…
Phase: PHASE4 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Brain zaps may restore speech and hand movement in stroke survivors
Knowledge-focused Recruiting nowThe goal of this study is to verify whether the use of deep brain stimulation can improve motor function of the hand and arm and speech abilities for people following a stroke. Participants will undergo a surgical procedure to implant deep brain stimulation electrode leads. The e…
Phase: NA • Sponsor: Jorge Gonzalez-Martinez • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Could a pill boost brain recovery after stroke? new trial begins
Disease control OngoingThe purpose of this interventional study is to determine whether neflamapimod can improve residual physical disability and/or cognitive dysfunction after Moderate to Severe Acute Ischaemic Stroke.
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New chemo combo strategy aims to outsmart pancreatic cancer
Disease control Recruiting nowA prospective, interventional, single-center, single-arm, open-label, phase II study for patients with metastatic pancreatic cancer. The intervention consists of monthly alternating standard chemotherapy regimens-NALIRIFOX and GnP. The hypothesis is that induction therapy with al…
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Simple urine test could spot bladder cancer early
Diagnosis Recruiting nowThe goal of this observational study is to further validate the sensitivity and specificity of Bladder EpiCheck in primary detection of urothelial carcinoma in participants aged 45 years or older presenting with haematuria, compared to cystoscopy and pathology, if performed. Par…
Sponsor: Nucleix Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Can a simple test predict CAR t success? new study hopes to find out
Knowledge-focused Recruiting nowThe INTeRCePT 2 study aims to develop a predictive assay to determine which patients with B cell lymphoma are most likely to respond to CAR T cell therapy. This assay combines five components for longitudinal profiling of each patient. The goal of the trial is that the assay can …
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New hope for arthritis sufferers: experimental drugs enter human trials
Disease control Recruiting nowRheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheum…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New depression drug SPT-300 enters Mid-Stage trial
Symptom relief Recruiting nowThis is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.
Phase: PHASE2 • Sponsor: Seaport Therapeutics • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
10-Year study tracks stent graft safety in 1,500 aortic patients
Disease control Recruiting nowAn observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical pr…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC